Monash IVF Group Discloses Interim Remuneration Package for Acting CEO

MT Newswires Live
2025/07/03

Monash IVF Group (ASX:MVF) disclosed the interim remuneration for acting Chief Executive Malik Jainudeen, effective June 12, reflecting the additional responsibilities of his role during the interim period, according to a Thursday filing with the Australian bourse.

Interim remuneration includes a fixed annual salary of AU$401,007 plus a AU$228,000 higher duties allowance, along with eligibility for a short-term incentive of up to 50% of total remuneration and a long-term incentive of up to 60% of base salary, both contingent on performance criteria, the filing said.

The appointment has no fixed term, includes a three-month notice, and will revert to Jainudeen's original remuneration terms after the interim period, the filing added.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10